| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 8e-05 |